Chemical Compound

etodolac

CAS Registry Number 41340-25-4
Back to search Request a Quote
etodolac chemical structure
Primary Record

etodolac

In stock
6,031 g
Purity
99.0 %
CAS
41340-25-4

Compound Identifiers & Properties

CAS
41340-25-4
PubChem CID
3308
SMILES
CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O
Canonical SMILES
CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3

Names & Synonyms

  • etodolac
  • Etodolic acid
  • Lodine
  • Ultradol
  • 41340-25-4
  • Ramodar
  • Edolan
  • Etodolaco
  • Zedolac
  • Lodine XL
  • Etodolacum
  • Tedolan
  • rac-Etodolac
  • Eccoxolac
  • Flancox
  • Napilac
  • Lodin xl
  • N-Methyl Etodolac
  • Hypen
  • etodine
  • Plerixafor
  • Etogesic
  • Ebretin
  • Osteluc
  • Etolyn
  • etodolac o
  • Lodine SR
  • (rs)-etodolic acid
  • Etodolie acid
  • rac Etodolac
  • Etodlic Acid
  • Etopan xl
  • EtoGesic Tablets
  • Etodolac ER
  • Etodolac CRS
  • rac Etodolac-d3
  • Etodolac(Lodine)
  • Etodolacum [INN-Latin]
  • Etodolaco [INN-Spanish]
  • Prestwick_209
  • Etodolacetodolic acid
  • Lodine (TN)
  • Etodolac (Standard)
  • AY-24236
  • Etodolac Assay Standard
  • Spectrum_001244
  • (R)-(-)-etodolac
  • (S)-(+)-etodolac
  • Etodolac, (S)-Isomer
  • CHEMBL622
  • ETODOLAC [USAN]
  • RefChem:55167
  • DTXSID9020615
  • ETODOLAC [INN]
  • ETODOLAC [JAN]
  • Etodolac, (-)-Isomer
  • AY-24,236
  • ETODOLAC [MI]
  • Etodolac impurity mixture
  • AY 24236
  • C17H21NO3
  • ETODOLAC [VANDF]
  • Opera_ID_1774
  • Prestwick0_000231
  • Prestwick1_000231
  • Prestwick2_000231
  • Prestwick3_000231
  • Spectrum2_001387
  • Spectrum3_001429
  • Spectrum4_000410
  • Spectrum5_001347
  • CCRIS 3923
  • CHEBI:4909
  • Etodolac [USAN:BAN:INN]
  • Etodolac [USAN:INN:BAN]
  • Etodolac, (+-)-Isomer
  • Etodolac, Monosodium Salt
  • NNYBQONXHNTVIJ-UHFFFAOYSA-N
  • (+/-)-ETODOLAC
  • ETODOLAC [MART.]
  • D0N1WU
  • DTXCID30615
  • Epitope ID:613427
  • ETODOLAC [USP-RS]
  • ETODOLAC [WHO-DD]
  • AC1L1FN2
  • MLS000028474
  • SCHEMBL3903
  • Lopac0_000479
  • BSPBio_000301
  • BSPBio_003138
  • KBioGR_000680
  • KBioSS_001724
  • Etodolac - Bio-X trade mark
  • MLS001077315
  • MLS006011566
  • NIH-9918
  • DivK1c_000147
  • ETODOLAC [GREEN BOOK]
  • NSC-282126
  • SPECTRUM1501005
  • Etodolac (JP18/USP/INN)
  • Etodolac [USAN:USP:INN:BAN]
  • RAK-591
  • SPBio_001374
  • SPBio_002222
  • ETODOLAC [ORANGE BOOK]
  • MFCD00133313
  • NSC282126
  • BPBio1_000333
  • GTPL7185
  • orb1310080
  • orb3025562
  • ETODOLAC [EP MONOGRAPH]
  • Etodolac for peak identification
  • ETODOLAC [USP MONOGRAPH]
  • NSC 282126
  • SCHEMBL29385172
  • CTK4I4719
  • ERK5-1E19
  • HMS500H09
  • KBio1_000147
  • KBio2_001724
  • KBio2_004292
  • KBio2_006860
  • KBio3_002358
  • CID3308
  • M01AB08
  • MSK8008
  • NINDS_000147
  • UNII-2M36281008
  • HMS1568P03
  • HMS1921B09
  • HMS2092O20
  • HMS2095P03
  • HMS2231D04
  • HMS3259P10
  • HMS3261O20
  • HMS3374G09
  • HMS3712P03
  • HMS5079D11
  • Pharmakon1600-01501005
  • BBC19746
  • BCP28411
  • CID:3308
  • 2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid
  • AY-24-236
  • Etogesic Sterile Injectable Solution
  • Tox21_110644
  • Tox21_202218
  • Tox21_500479
  • 1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid
  • ANW-42024
  • BDBM50016799
  • C17-H21-N-O3
  • CCG-39005
  • CE0096
  • EBC-11162
  • Etodolac for peak identification CRS
  • HY-76251R
  • MSK8008-100A
  • NSC757821
  • SMR000058443
  • AKOS015838610
  • MSK8008-1000A
  • Tox21_110644_1
  • AC-4231
  • AY 24,236
  • CS-0832
  • DB00749
  • FR27516
  • KS-1056
  • LP00479
  • LS-7393
  • NC00718
  • NSC-757821
  • RTR-036749
  • SDCCGSBI-0050463.P004
  • 1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid
  • 1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
  • Etodolac, Monosodium Salt, (S)-Isomer
  • IDI1_000147
  • KS-0000000W
  • NCGC00015399-03
  • NCGC00015399-04
  • NCGC00015399-05
  • NCGC00015399-06
  • NCGC00015399-07
  • NCGC00015399-08
  • NCGC00015399-09
  • NCGC00015399-11
  • NCGC00015399-12
  • NCGC00015399-13
  • NCGC00015399-15
  • NCGC00015399-16
  • NCGC00015399-26
  • NCGC00015399-27
  • NCGC00016849-01
  • NCGC00089769-02
  • NCGC00089769-03
  • NCGC00089769-04
  • NCGC00089769-05
  • NCGC00089769-06
  • NCGC00089769-07
  • NCGC00259767-01
  • NCGC00261164-01
  • AK550845
  • AN-12214
  • BC651843
  • BR164431
  • CPD000058443
  • Etodolac, Monosodium Salt, (+-) Isomer
  • HY-76251
  • J16.541G
  • Pyrano[3,4-b]indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-
  • SAM002589968
  • SID:53786741
  • SY057989
  • 2-{1,8-diethyl-1H,3H,4H,9H-pyrano[3,4-b]indol-1-yl}acetic acid
  • SBI-0050463.P003
  • 2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid
  • AB0012214
  • CAS-41340-25-4
  • Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-
  • TR-036749
  • 2M36281008
  • AB00052194
  • E-140
  • E0858
  • Etodolac Solution in Acetonitrile, 100ug/mL
  • EU-0100479
  • FT-0607046
  • FT-0668424
  • FT-0668425
  • NS00010209
  • Etodolac Solution in Acetonitrile, 1000ug/mL
  • C06991
  • D00315
  • E 0516
  • EN300-119494
  • Etodolac, 98%, a COX inhibitor - 25G 25g
  • K-8734
  • Pyrano[3, 1,8-diethyl-1,3,4,9-tetrahydro-
  • AB00052194_17
  • (+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
  • (1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid
  • (1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid
  • 340E254
  • A825520
  • D017308
  • F358075
  • SR-01000000100
  • Q2465218
  • SR-01000000100-2
  • SR-01000000100-4
  • SR-01000000100-7
  • BRD-A74667430-001-05-3
  • BRD-A74667430-001-15-2
  • BRD-A74667430-001-23-6
  • (RS)-2-(1,8-Diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid
  • 1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid
  • 849630-94-0
  • Etodolac, European Pharmacopoeia (EP) Reference Standard
  • F2173-0681
  • Z1521549186
  • 1,8-diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indole-1-acetic acid
  • 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid
  • Pyrano(3,4-b)indole-1-acetic acid, 1,3,4,9-tetrahydro-1,8-diethyl-
  • (+)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid
  • (+/-)-1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
  • Etodolac, United States Pharmacopeia (USP) Reference Standard
  • Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-(+-)-
  • 1,3,4,9-Tetrahydro-1,8-diethylpyrano[3,4-b]indole-1-acetic acid
  • 1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indol-1-ylacetic acid
  • 1,8-Diethyl-1,3,4,9-tetrahydropyranol[3,4-b]indole-1-acetic acid
  • 2-(1,8-Diethyl-1H,3H,4H,9H-pyrano[3,4-b]indol-1-yl)acetic acid
  • (-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid
  • (1,8-Diethyl-1,3,4,9-tetrahydro-pyrano(3,4-b)indol-1-yl)-acetic acid
  • [1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid
  • 1,8-DIETHYL-1,3,4,9-TETRAHYDROPYRANO(3,4-B)INDOL-1-ACETIC ACID
  • 2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid.
  • Pyrano(3,4,b)indole-1-acetic acid, 1,3,4,9-tetrahydro-1,8-diethyl-
  • ((+/-)-8-ethyl-1-methyl-1,3,4,9-tetrahydropyrano [3,4-b]-indole-1-acetic acid)
  • (R)-2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid
  • 1,4,8,11-Tetraazacyclotetradecane, 1,1'-[1,4-phenylenebis(methylene)]bis-
  • 2-((1RS)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indol-1-yl)acetic acid
  • AY 24,236; AY 24236;AY-24,236; AY-24236; AY24,236; AY24236
  • Etodolac for peak identification, European Pharmacopoeia (EP) Reference Standard
  • PYRANO(3,4-B)INDOLE-1-ACETIC ACID, 1,8-DIETHYL-1,3,4,9-TETRAHYDRO-(+/-)-
  • 1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic Acid; 1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid; (+/-)-Etodolac; (RS)-Etodolic acid; Edolan; Etodolac; Etodolic acid; Etogesic; Lodin XL; Lodine; Ramodar; Tedolan; Ultradol; Zedolac
  • 109518-50-5
  • 110078-46-1
  • 1276197-46-6
  • 87226-41-3
  • 87249-11-4
  • ETD
  • Etodolac, AY 24,236, AY 24236, AY-24,236, AY-24236, AY24,236, AY24236, 1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic Acid